Unusual Machines
UMAC
21.88
-0.48
-2.15%
Unusual Machines
US · UMAC
#3188 by market cap
Listed 2024
21.88
-0.48
-2.15%
Live - 5344 symbols - heartbeat 285s ago
· 2026-10-08 09:19
Pre-market
21.79
-0.41%
After-hours
22.00
+0.55%
Overnight
21.55
-1.51%
- Market cap
- 1.09B
- P/E (TTM)i
- -156.29
- P/Bi
- 2.82
- EPSi
- -0.74
- Div yieldi
- 0.00%
- 52W posi
- 53%
Reader sentiment
Are you bullish or bearish on UMAC?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 84.63, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 5 years
Latest year +101.23% YoY
Margins
- Gross margin
- 34.89%
- Operating margin
- -224.59%
- Net margin
- -171.38%
Key ratios & quality
- Altman Z-Scorei
- 84.63
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4.99K | 0 | 0 | 5.57M | 11.20M |
| Gross profit | 4.99K | 0 | 0 | 1.55M | 3.91M |
| Selling & admin expenses | 166.87K | 1.08M | 2.38M | 7.34M | 25.48M |
| Research & development | 0 | 91.33K | 0 | 90.58K | 202.59K |
| Operating profit | -161.88K | -1.17M | -2.38M | -6.92M | -25.15M |
| Pretax profit | -161.88K | -1.17M | -2.38M | -31.99M | -19.23M |
| Tax | 0 | 0 | 0 | -13.36K | -36.25K |
| Net profit | -161.88K | -1.17M | -2.38M | -31.98M | -19.19M |
| Basic EPS | 0 | 0 | 0 | -4 | -1 |
| Diluted EPS | -0.02 | -0.15 | -0.31 | -3.84 | -0.74 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 2.04M | 2.12M | 2.13M | 4.90M | 8.10M | 16.72M |
| Gross profit | 496.81K | 794.68K | 840.39K | 1.77M | 2.65M | 5.80M |
| Selling & admin expenses | 3.43M | 7.50M | 5.10M | 9.45M | 7.81M | 11.59M |
| Research & development | 7.90K | 62.73K | 39.37K | 92.58K | 91.14K | 430.76K |
| Operating profit | -3.27M | -7.19M | -4.96M | -9.73M | -7.26M | -7.83M |
| Pretax profit | -3.27M | -6.96M | 1.60M | -10.60M | 10.28M | -7.78M |
| Tax | 0 | -- | -- | -- | 0 | -- |
| Net profit | -3.27M | -6.96M | 1.60M | -10.57M | 10.28M | -7.78M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.21 | -0.32 | 0.05 | -0.36 | 0.21 | -0.16 |
Balance sheet
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total current assets | 3.90M | 3.14M | 1.02M | 6.10M | 159.51M |
| Cash & ST investments | 3.79M | 3.10M | 894.77K | 3.76M | 142.48M |
| Inventory | -- | -- | 0 | 1.34M | 5.32M |
| Total assets | 3.90M | 3.33M | 1.53M | 16.11M | 182.71M |
| Total current liabilities | 0 | 131.93K | 114.50K | 933.67K | 2.60M |
| Short-term debt | -- | -- | -- | 67.82K | 456.43K |
| Long-term debt | -- | -- | -- | -- | -- |
| Total liabilities | 0.00 | 131,931.00 | 114,497.00 | 1,289,633.00 | 7,768,745.00 |
| Total equity | 3.90M | 3.20M | 1.41M | 14.82M | 174.94M |
| Retained earnings | -296.01K | -1.55M | -3.93M | -35.91M | -55.11M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 7.31M | 42.22M | 91.70M | 159.51M | 315.21M | 370.58M |
| Cash & ST investments | 5.00M | 38.93M | 81.14M | 142.48M | 283.60M | 316.37M |
| Inventory | 1.21M | 1.61M | 3.12M | 5.32M | 13.83M | 21.91M |
| Total assets | 17.28M | 52.45M | 113.08M | 182.71M | 339.70M | 397.49M |
| Total current liabilities | 1.05M | 821.70K | 5.93M | 2.60M | 2.46M | 6.89M |
| Short-term debt | 70.65K | 73.57K | 247.96K | 456.43K | 714.14K | 735.52K |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 1,385,414.00 | 1,139,253.00 | 7,062,903.00 | 7,768,745.00 | 8,065,652.00 | 9,452,411.00 |
| Total equity | 15.90M | 51.31M | 106.02M | 174.94M | 331.64M | 388.04M |
| Retained earnings | -39.18M | -46.14M | -44.54M | -55.11M | -44.82M | -52.61M |
Cash flow
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | -162.82K | -1.19M | -1.78M | -4.00M | -21.18M |
| Depreciation & amortization | 0 | 885 | 5.60K | 72.16K | 141.27K |
| Free cash flow | -162.82K | -1.19M | -1.78M | -4.00M | -23.24M |
| Dividends paid | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 3.95M | 549.90K | 0 | 7.05M | 160.65M |
| Ending cash balance | 3.79M | 3.10M | 894.77K | 3.76M | 103.26M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -1.19M | -2.67M | -7.53M | -9.78M | -17.41M | -21.48M |
| Depreciation & amortization | 20.59K | 20.59K | 22.45K | 77.63K | 64.81K | -415.65K |
| Free cash flow | -1.19M | -2.93M | -8.82M | -10.29M | -18.11M | -21.29M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 42.44M | 46.06M | 72.15M | 150.00M | 63.40M |
| Ending cash balance | 5.00M | 38.93M | 64.29M | 103.26M | 222.94M | 229.60M |
Returns & efficiency
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| ROE %i | -4.15 | -34.95 | -77.61 | -394.02 | -20.23 |
| ROA %i | -4.15 | -34.36 | -73.85 | -362.65 | -19.31 |
| ROIC %i | -4.15 | -34.95 | -77.61 | -377.26 | -21.81 |
| 5-year avg ROE %i | -- | -- | -- | -- | -110.95 |
| EBIT margin %i | -3,244.72 | -- | -- | -572.78 | -171.70 |
| FCF / sales %i | -- | -- | -- | -- | -- |
| Current ratioi | -- | 23.79 | 8.87 | 6.53 | 61.32 |
| Quick ratioi | -- | 23.49 | 7.81 | 4.10 | 55.45 |
| Debt / assetsi | -- | -- | 0.00 | 2.05 | 1.44 |
| LT debt / equityi | -- | -- | -- | 1.77 | 1.24 |
| Interest coveragei | -- | -- | -- | -272.50 | -37,050.77 |
| Revenue CAGR (3Y) %i | -- | -- | -- | 937.11 | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -183.96 | -110.81 | -57.08 | -20.23 | -3.25 | -2.94 |
| ROA %i | -164.50 | -101.73 | -51.95 | -19.31 | -3.16 | -2.87 |
| ROIC %i | -171.06 | -104.47 | -56.48 | -21.81 | -4.70 | -4.82 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -487.31 | -512.23 | -430.39 | -171.70 | -32.92 | -20.40 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 6.97 | 51.38 | 15.45 | 61.32 | 128.23 | 53.82 |
| Quick ratioi | 4.82 | 47.59 | 13.73 | 55.45 | 116.83 | 47.49 |
| Debt / assetsi | 1.82 | 0.57 | 1.13 | 1.44 | 0.98 | 0.79 |
| LT debt / equityi | 1.53 | 0.44 | 0.98 | 1.24 | 0.79 | 0.62 |
| Interest coveragei | -349.90 | -694.56 | -2,331.15 | -37,050.77 | -6,403.28 | -5,568.33 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 09:19:41 · For reference only, not investment advice and not tailored to your situation.